Recent Blog Posts

View Post: Omalizumab benefits Asian asthma patients
26 Nov 2009
Omalizumab improves disease control in Asian patients with moderate-to-severe asthma without causing any significant adverse events, researchers report in findings that are consistent with those from studies conducted in other ethnic ...
View Blog: MedWire News - Respiratory - http://www.medwire-news.md/48/Respiratory.html

---

View Post: FDA panel rejects omalizumab (Xolair®) for treatment of asthma in ...
20 Nov 2009
An advisory panel to the FDA has voted 10 to 4 against approval of omalizumab (Xolair®) for the treatment of asthma in children aged 6 to 11 years. The committee was split evenly on the effectiveness of the drug but voted by 9 to 5 that ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: Omalizumab for asthma
17 Nov 2009
The US Food and Drug Administration said studies with the asthma drug Xolair, omalizumab marketed by Novartis AG (NVS) and Genentech, showed it has "modest" benefits in children ages six to 11. ...
View Blog: Current R&D of Pharmaceutical - http://www.cradop.com/component/content/frontpage.html

---

View Post: Omalizumab As An Allergic Asthma Treatment
24 Nov 2009 by author  
Allergic asthma is the display of asthma symptoms as a part of an allergic reaction. Inadvertent inhalation of allergens or ingestion of food proteins can trigger some people's immune system to overreact and IgE to bind to mast cells. ...
View Blog: Asthma and Allergies: News and Views »... - http://asthmaforthelayman.com/blog/

---

View Post: Omalizumab for Allergic Asthma
1 Nov 2009 by admin  
In 2003, a medicine known as "Omalizumab" was approved for use against allergic asthma. It is also known as “Anti-IgE”. This drug is administered subcutaneously every 2 or 4 weeks. It got its nickname because Omalizumab binds free IgE ...
View Blog: Ionic Air Purifier Store - http://ionicairpurifierstore.com/

---

View Post: Effect of omalizumab on peripheral blood eosinophilia in allergic ...
21 Oct 2009 by M. Massanari, S.T. Holgate, W.W. Busse,...  
We assessed the effect of omalizumab on peripheral blood eosinophil counts using a pooled analysis of data from five randomized, double-blind, placebo-controlled studies in patients with moderate-to-severe persistent allergic asthma ...
View Blog: Sc Scandium - http://sc-scandium.info/

---